{"url_path":"/sec/prok/8-k/2026-05-15/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1850270/0001193125-26-225848-index.html","accession_number":"0001193125-26-225848","cik":"0001850270","ticker":"PROK","issuer_name":"PROKIDNEY CORP.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1850270/0001193125-26-225848-index.html","primary_entity_key":"0001850270","primary_entity_name":"PROKIDNEY CORP."},"word_count":131,"has_tables":true,"body_markdown":"## Item 2.02 Results of Operations and Financial Condition.\n\nOn May 15, 2026, ProKidney Corp. (the \"Company\") issued a press release to announce its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1.\n\nThe information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18, of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}